Chris Harbert Email & Phone Number

Boston, MA, US

California, US

We envision a future where a network of intelligent robots enhances human potential, allowing people to unlock new levels of productivity and live fuller, more meaningful lives. With offices in China, Japan, and the US, along with partnerships around the globe, ForwardX is expanding and applying its proven solutions to warehouses and manufacturers.

Boston, Massachusetts, US

External Advisor to the rebirth of the original collaborative robot pioneer, Rethink Robotics.

Roswell, Georgia, US

GreyOrange is driving the intersection of three key technologies that are shaping the future: Artificial Intelligence, Machine Learning and Robotics. Our always-solving fulfillment orchestration platform, GreyMatter, optimizes real-time decisions involving inventory, order promises, people and robots so distribution operations perform at peak efficiency.

Guildford, England, GB

Columbus, Ohio, US

Exploded revenue pipeline by >10x in under six months. Restructured entire sales process, standardizing methods in lead qualification, pipeline management, and account management. Guided major overhaul in go-to-market messaging and positioning. Co-developed new sales tools and service offerings to shorten sales cycle and increase average deal value by over.

Wilmington, MA, US

Managed a stellar team of Sales, Business Development, and Solution Design Engineering professionals, in a player/coach role, servicing a broad array of markets including Healthcare/Biomedical, Automotive & Aerospace, Third-Party Logistics and Warehousing Providers, and Retail.

Wilmington, MA, US

Lead enterprise sales effort for Retail and Life Sciences markets. Built revenue pipeline through outreach, networking, lead vetting and thorough qualification. Revised project proposal process to maximize customer engagement and commitment. Supported outbound marketing campaigns, tradeshows, and other customer-focused events.

Responsible for all North American revenue. Lead team of field-based Sales Engineers/Managers and oversaw 20+ regional Channel Partners across the US, Canada and Mexico. Developed and executed strategic growth plan to maximize revenue growth while preserving ASP and contribution margin, and growing revenue from $6M to $11M in 2 years.

Directed B2B and Channel sales of Rethink Robotics Research & Education Platform - Baxter Research Robot - in 18 countries across 5 continents. Established international distribution channels in APAC and the EU, growing revenue for the segment from $0 to $6M in 2 years. Established EU distribution channel for company's second generation product, Sawyer.

Managed direct and distribution sales of Rethink Robotics Research & Education Platform - Baxter Research Robot - in 18 countries across 5 continents. Maintained > 25% Q/Q growth and grew sales from $0 to $5M in three years. Managed direct sales of Rethink Robotics Manufacturing Platform - Baxter Robot - to large, multi-facility companies across the U.S..

Rethink Robotics is creating a new category of robots for manufacturing that will dramatically increase the productivity of manufacturing labor, change the definition of how and where robots can be used, and redefine the economics of the robotics industry. More importantly Rethink's robots will change the economics of manufacturing common everyday.

• Manage strategic and tactical aspects of the flagship XF Platform to maximize hardware and consumables revenue. Represent VOC in liaison with R&D, Marketing, and Sales/Support. Identify, prioritize, and execute.
• Led the development and launch of five new consumable products in first 12 months on the job, doubling the company’s consumable portfolio
• Led new quality initiatives in consumables manufacturing to improve reliability and performance
• Team leader in creation of new product development pipeline
• Developed new product line tracking and analytics, illustrating key market opportunities
• Established 3rd party collaboration to deliver key hypoxia application solution for XF product line

• Lead a multidisciplinary product team (Engineering, Biology, Marketing) in the design and development of a novel cell culture automation system. Perform market segmentation analysis to determine risk/reward profile for.
• Developed product messaging, pricing strategy, and market penetration plan
• Assembled KOL panel from leading institutions (GSK, Novartis, Harvard Medical School, Yale University, NIH, BMS) for design meetings and alpha/beta testing
• Drove design/layout efforts to optimize workflow and reduce footprint by 55%
• Delivered comprehensive market analysis and business plan to senior management

• Manage all aspects of regional marketing communications, including campaign strategy and execution, collateral development, ad stream optimization, tradeshow strategy and logistics. Refine product messaging and.
• Led development of new service offering from concept to launch; >$300,000 in first-year revenue
• Increased regional ad response rate by 300%
• Assembled first North American KOL panel and developed accompanying global digital campaign
• Coordinated US beta-testing and launch of new qPCR product platform ($1M in revenues during first 9 months post-launch)
• Developed Exiqon “Grant Program”, delivering >$200,000 in new business revenue (concept subsequently adopted by competitors Applied Biosystems, LC Sciences, and Illumina)

• Develop key New England territory to increase adoption of Exiqon microRNA products and services. Develop relationships with leaders in Academic, Biotech, and Pharmaceutical sectors. Use scientific background and.
• Doubled territory revenue during first 6 months in the field
• Penetrated previously unavailable Pharmaceutical segment through networking efforts and product positioning tactics

Codolet, FR

• Manage internal and field-based Scientific Consults providing pre-sale and post-sale technical support for Cisbio products and services. Develop internal training programs to maximize team efficacy and minimize.
• Developed and defined the Scientific Consultant functional role within the organization together with North American management team
• Reduced scientific staff turnover from 30% to 0% in first year; grew scientific team by 25% in same time period
• Increased Laboratory Services revenue >61% in first year with launch of new service products
• Increased laboratory throughput by 300% by consolidating supply chain and revising production workflow

• Develop Northeast territory to increase penetration of Cisbio high-throughput screening reagents and services. Develop relationships with thought leaders in the Drug Discovery marketplace. Use scientific background and.
• Grew revenue by 30% in first year, maintained highest quota in North America
• Increased company penetration at major pharma sites – BMS, Novartis, Pfizer, Abbott
• Delivered 75% of high-margin Custom Laboratory Services revenue in North American region

• Provide pre- and post-sales support, including on-site product demonstrations, pre-sales presentations, customer training and troubleshooting. Assist account penetration and development of sales opportunities in new.
• Rapidly assumed applications support for half of North American customers.
• Co-developed training programs for new hires
• Increased on-site demo success rate, translated to higher sales conversion rate

• Coordinate transfer of screening targets from therapeutic areas to high-throughput screening department. Validate therapeutic assays in HTS mode, re-optimize as required. Design and optimize automation protocols for.
• Completed cell-based assay screens with average CV <10%
• Delivered primary screen, IC50 and SAR data for leading antibiotic discovery project (MurA)

• Execute in vitro selection of high-affinity reagents with peptide and antibody-mimic libraries. Characterize lead compounds for target binding, affinity determination. Execute a variety of selection-related procedures.
• Delivered sequencing validation data to secure milestone payment from discovery partner (Cubist Pharmaceuticals)
• Developed high-throughput validation assay for lead compound characterization using FRET technology

Medford, Massachusetts, US

Dose-response determination for mast cell histamine release: animal handling/surgery, primary cell culture, cell harvest and isolation, receptor inhibition studies, time-course analysis, fluorometry. Dr. David E. Cochrane, Ph.D, Principal Investigator.

Mba, Management

B.S., Biology

Bachelor Of Arts, Romance Languages

Bachelor Of Arts, Music